»ï¼º¼¿ïº´¿ø Prosthetic Valve Selection in Korea : 2019-03-09±³À°ÀÏÀÚ : 2019-03-09
±³À°Àå¼Ò : »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
Prosthetic Valve Selection in KoreaÁÖÃÖ±â°ü : »ï¼º¼¿ïº´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ÈäºÎ¿Ü°ú
´ã´çÀÚ : ¹ÚÁÖ¿¬
¿¬¶ôó : 02-3410-3489
À̸ÞÀÏ :
sd000.park@samsung.com ±³À°Á¾·ù : ±âŸ
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 7 ½Ã°£ 45ºÐ
¼¼ºÎ¼ö°·á : 30,000¿ø
ºñ°í »çÀüµî·Ï-20,000 / ´çÀϵî·Ï-30,000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 08:00~08:05 Ãà»ç ¿ÀÀç°Ç(»ï¼º¼¿ïº´¿ø)
±âŸ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 08:05~08:10 Program ¼Ò°³ ¹ÚÇ¥¿ø(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 08:10~08:25 Current AHA & ESC guide for valve ion ±èÀº°æ(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 08:25~08:40 Design & hemodynamics of prosthetic mechanical valve ÀÓû(ºÐ´ç¼¿ï´ëº´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 08:40~08:55 Design & hemodynamics of prosthetic tissue valve À¯Àç¼®(¼¼Á¾º´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 08:55~09:15 Long-term problems and mode of failure of mechanical valve Á¤µ¿¼·(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 09:15~09:30 Long-term problems and mode of failure of tissue valve ¹Ú¼ºÁö(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 09:30~09:45 Late outcomes of TAVI: AMC experience ¹Ú´ö¿ì(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 09:45~10:05 SMC experience of TAVI ¹ÚÅñÔ(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 10:05~10:25 Role of rapid deployment or sutureless AVR ±è°æȯ(¼¿ï´ëÇк´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 10:25~10:40 Role of surgical AVR in TAVI era ¹ÚÇ¥¿ø(»ï¼º¼¿ïº´¿ø)
ÈÞ½Ä 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 10:40~11:00 Break ()
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 11:00~11:15 Operative or interventional indications of aortic valve disease ¿ÀÀç°Ç(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 11:15~11:35 Valve ion in middle age: mechanical vs tissue valve ÀÌ»è(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 11:35~11:55 Current results of repeated surgical AVR ¼º±âÀÍ(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 11:55~12:10 Current status of valve-in-valve TAVR Jien Ye(Vancouver General Hospital)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 12:10~12:20 St. Jude standard valve vs Regent ±èÈ£Áø(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 12:20~12:30 Mechanical AVR: old vs new mechanical valve ÀÌÈñ¹®(¼¼Á¾º´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 12:30~12:40 Tissue valve AVR: porcine vs bovine AVR ±èÁعü(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 12:40~12:50 Carpentier-Edwards pericardial valve: Perimount vs Magna ÀåÇü¿ì(ºÐ´ç¼¿ï´ëº´¿ø)
½Ä»ç 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 12:50~13:50 Lunch ()
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 13:50~14:05 Age criteria of tissue valve ion in MVR ÀÌÀç¿ø(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 14:05~14:25 Outcomes of repeat surgical MVR À̽ÂÇö(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 14:25~14:40 Current status of valve in valve MVR Jien Ye(Vancouver General Hospital)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 14:40~14:50 Late clinical outcomes of tissue valve MVR: Porcine vs Bovine ±èÁعü(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 14:50~15:00 Is PPM important in MVR? Ȳȣ¿µ(¼¿ï´ëÇк´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 15:00~15:10 Late outcomes of mechanical MVR in rheumatic disease Á¤¼ö·Ã(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 15:10~15:20 Metal surface area in mechanical MVR Á¶¾çÇö(»ï¼º¼¿ïº´¿ø)
ÈÞ½Ä 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 15:20~15:35 Break ()
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 15:35~15:50 Selection of prosthetic valve in TVR: mechanical vs tissue Prefer tissue valve Ȳȣ¿µ(¼¿ï´ëÇк´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 15:50~16:10 Prefer mechanical valve ¹ÚÇ¥¿ø(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 16:10~16:30 Future perspective of transcatheter procedure in TV position Jien Ye(Vancouver General Hospital)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 16:30~16:50 Optimal anticoagulation after valve surgery À庴ö(ºÐ´çÂ÷º´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 16:50~17:10 Prosthetic valve ion in Mayo clinic ¿ÀÀç°Ç(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 03-09 »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç 17:10~17:30 Prosthetic valve ion in SMC ¹ÚÇ¥¿ø(»ï¼º¼¿ïº´¿ø)